Coya Therapeutics, Inc. Common Stock (COYA) Live Share Price, Invest From India

Coya Therapeutics, Inc. Common Stock Stock Performance

as on April 22, 2026 at 6:59 am IST

Day's High
$4.52
Day's Price Range
$5.05
$4.52
11.73%
Upside
52 Week's Low
52 Week's High
$3.71
52-Week Price Range
$7.75
$4.52
17.92%
Downside
71.46%
Upside

Coya Therapeutics, Inc. Common Stock share price movements today

Previous Close: $4.99
Open: $5.00
Volume: 471.7K
Day's Low - High: $4.52 - $5.05
52 Week Low - High: $3.71 - $7.75

Coya Therapeutics, Inc. Common Stock Historical Returns

1 Month Return: + 18.53 %
3 Month Return: + 9.67 %
1 Year Return: -12.61 %
3 Year Return: + 6.17 %
5 Year Return: 0 %

Coya Therapeutics, Inc. Common Stock Stock Fundamentals & Key Indicators

Check Coya Therapeutics, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$112.1M

EPS (TTM)

-1.64

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-20.2M

Revenue (TTM)

7.9M

Profit Margin

-267.14%

Return On Equity TTM

-51.39%

Coya Therapeutics, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Coya Therapeutics, Inc. Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Coya Therapeutics, Inc. Common Stock	BUY	$112.1M	NA	NA	-267.14%
Alnylam Pharmaceuticals Inc	BUY	$41.3B	126.09%	133.47	8.45%
Vertex Pharmaceuticals Inc	BUY	$111.7B	99.85%	28.65	32.94%
BeiGene, Ltd.	NA	$36.5B	NA	128.25	5.37%
Regeneron Pharmaceuticals Inc	BUY	$79.2B	47.96%	18.05	31.41%

Stock Returns calculator for Coya Therapeutics, Inc. Common Stock Stock including INR - Dollar returns

The Coya Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Coya Therapeutics, Inc. Common Stock investment value today

Current value as on today

₹86,896

Returns

-₹13,104

(-13.1%)

Returns from Coya Therapeutics, Inc. Common Stock Stock

-₹20,841 (-20.84%)

Dollar Impact

₹7,737 (+7.74%)

Analyst Recommendation on Coya Therapeutics, Inc. Common Stock Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Coya Therapeutics, Inc. Common Stock. Average target price of $15.64

Coya Therapeutics, Inc. Common Stock Share Price Target

Get share price movements and forecasts by analysts on Coya Therapeutics, Inc. Common Stock.

What analysts predicted

71.1%UPSIDE

Target Price

$15.64

Current Price

$4.52

Analyzed by

8 Analysts

Target

$15.64

Coya Therapeutics, Inc. Common Stock target price $15.64, a slight upside of 71.1% compared to current price of $4.52. According to 8 analysts rating.

Coya Therapeutics, Inc. Common Stock Stock’s Investor Sentiment and Interest

Search interest for Coya Therapeutics, Inc. Common Stock Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Time period: March 23, 2026 to April 22, 2026

Change:100% versus previous 30 day period

Coya Therapeutics, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	6	0	3	-	0	0	0	3	3
Gross Profit	-1	4	-3	-1	-2	-1	-4	0	3	9
Operating Income	-3	1	-5	-3	-4	-4	-7	-6	-1	-4
EBITDA	-3	2	-5	-3	-4	-4	-7	-6	-2	-4
Interest Expense	-	0	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-3	1	-5	-2	-4	-3	-7	-6	-2	-5
Income Tax Expense	0	0	0	-	0	0	720	-	-	0
Net Income	-3	1	-5	-2	-4	-2	-7	-6	-2	-5
Net Profit Margin	0.00%	21.09%	-3982.96%	-84.42%	0.00%	-149373.77%	-2833.35%	-3725.17%	-59.36%	-144.16%

Coya Therapeutics, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	6	3	7
Gross Profit	0	-4	0	-8	7
Operating Income	-4	-9	-7	-17	-20
EBITDA	-4	-9	-7	-17	-20
Interest Expense	0	2	-	-	-
Depreciation	0	0	0	0	0
Income Before Tax	-4	-12	-7	-15	-21
Income Tax Expense	0	2	0	0	0
Net Income	-4	-12	-7	-14	-21
Net Profit Margin	0.00%	0.00%	-133.08%	-418.70%	-267.14%

Coya Therapeutics, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	1	-5	-2	-4	-2	-7	-6	-2	-13,394
Operating Cash Flow	-2	2	-4	-5	-2	-2	-5	-1	-1
Investing Cash Flow	0	0	-	-	-	-24	-	0	0
Financing Cash Flow	24	1	5	0	9	0	-	0	20
Change in Cash	21	3	0	-5	7	-2	-5	-1	18

Coya Therapeutics, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-4	-12	-7	-14	-21
Operating Cash Flow	-3	-7	-11	-10	-10
Investing Cash Flow	0	0	0	0	-1
Financing Cash Flow	0	9	38	16	20
Change in Cash	-4	1	26	5	8

Insights on Coya Therapeutics, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, COYA stock has moved up by 11.9%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 38.8% return, outperforming this stock by 51.4%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 23.1% return, outperforming this stock by 16.9%

About Coya Therapeutics, Inc. Common Stock

Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary therapies to enhance the function of regulatory T cells (Tregs). Its candidate product pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. The company develops COYA 302, a biologic combination for subcutaneous administration intended to enhance Treg function while depleting T effector function and activated macrophages in Phase 2 trial for use in the treatment of amyotrophic lateral sclerosis, as well as frontotemporal dementia, Alzheimer's disease (AD), and Parkinson's disease. In addition, its pre-clinical product candidates include COYA 301, a low-dose interleukin 2 product candidate to treat AD; COYA 303, an investigational biologic combination of COYA 301 and a glucagon-like-peptide-1 receptor agonist for the treatment of inflammatory diseases; COYA 201, an antigen directed Treg-derived exosome product candidate to treat neurodegenerative, autoimmune, and metabolic diseases; COYA 206, an antigen directed Treg-derived exosome product candidate; and COYA 101. It has a collaboration with Dr. Reddy's Laboratories SA for the development and commercialization of COYA 302, an investigational combination therapy for treatment of amyotrophic lateral sclerosis. Coya Therapeutics, Inc. was founded in 2020 and is headquartered in Houston, Texas.

Organisation	Coya Therapeutics, Inc. Common Stock
Headquarters	5850 San Felipe St., Houston, TX, United States, 77057
Industry	Biotechnology
CEO	Dr. Arun Swaminathan Ph.D.
E-voting on shares	Click here to vote

Key Management of Coya Therapeutics, Inc. Common Stock

Name	Title
Mr. Aaron Thome Ph.D.	Head of Neuroinflammation Platform
Dr. Michelle Frazier Ph.D.	Senior Vice President of Regulatory
Ms. Karen King M.S.	Senior VP of Program Management & Clinical Operations
Dr. Arun Swaminathan Ph.D.	CEO & Director
Dr. Fred Grossman D.O., FAPA	President & Chief Medical Officer
Mr. David S. Snyder M.B.A.	CFO & COO

FAQs

What is Coya Therapeutics, Inc. Common Stock share price today?

Coya Therapeutics, Inc. Common Stock share price today is $4.52 as on April 22, 2026 at 1:29 am IST at the close of the market. Coya Therapeutics, Inc. Common Stock share today touched a day high of $5.05 and a low of $4.52.

What is the 52 week high and 52 week low for Coya Therapeutics, Inc. Common Stock share?

Coya Therapeutics, Inc. Common Stock share touched a 52 week high of $7.75 on October 14, 2025 and a 52 week low of $3.71 on March 30, 2026. Coya Therapeutics, Inc. Common Stock stock price today i.e. April 22, 2026 at 1:29 am IST is closed at $4.52,which is 41.68% down from its 52 week high and 21.83% up from its 52 week low.

What is Coya Therapeutics, Inc. Common Stock's market capitalisation today?

Coya Therapeutics, Inc. Common Stock market capitalisation is $0.00T as on April 22, 2026 at 1:29 am IST.

How to invest in Coya Therapeutics, Inc. Common Stock Stock (COYA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Coya Therapeutics, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Coya Therapeutics, Inc. Common Stock Shares that will get you 0.3319 shares as per Coya Therapeutics, Inc. Common Stock share price of $4.52 per share as on April 22, 2026 at 1:29 am IST.

What is the minimum amount required to buy Coya Therapeutics, Inc. Common Stock Stock (COYA) from India?

Indian investors can start investing in Coya Therapeutics, Inc. Common Stock (COYA) shares with as little as ₹93.505 or $1 (as of April 22, 2026 at 3:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹935.05 in Coya Therapeutics, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on April 22, 2026 at 3:37 am IST). Based on Coya Therapeutics, Inc. Common Stock share’s latest price of $4.52 as on April 22, 2026 at 1:29 am IST, you will get 2.2124 shares of Coya Therapeutics, Inc. Common Stock. Learn more about fractional shares .